6.24
price up icon54.07%   2.19
after-market アフターアワーズ: 5.91 -0.33 -5.29%
loading
前日終値:
$4.05
開ける:
$6.3
24時間の取引高:
83.49M
Relative Volume:
60.19
時価総額:
$11.73M
収益:
$15.66M
当期純損益:
$5.83M
株価収益率:
-0.2612
EPS:
-23.8939
ネットキャッシュフロー:
$466.20K
1週間 パフォーマンス:
-59.79%
1か月 パフォーマンス:
-45.50%
6か月 パフォーマンス:
+20.23%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$5.66
$8.44
1週間の範囲:
Value
$3.75
$17.19
52週間の値動き範囲:
Value
$2.90
$21.40

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Name
名前
Neuphoria Therapeutics Inc
Name
セクター
Healthcare (1140)
Name
電話
781-439-5551
Name
住所
100 SUMMIT DR, BURLINGTON
Name
職員
8
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
NEUP's Discussions on Twitter

NEUP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NEUP
Neuphoria Therapeutics Inc
6.24 9.55M 15.66M 5.83M 466.20K -23.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-09-28 アップグレード H.C. Wainwright Neutral → Buy
2023-09-28 繰り返されました Maxim Group Buy
2022-01-10 開始されました Berenberg Buy
2022-01-10 開始されました Cantor Fitzgerald Overweight
2022-01-10 開始されました Evercore ISI Outperform
2022-01-10 開始されました H.C. Wainwright Buy
すべてを表示

Neuphoria Therapeutics Inc (NEUP) 最新ニュース

pulisher
12:06 PM

Can Neuphoria Therapeutics Inc. stock hit analyst price targets2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com

12:06 PM
pulisher
Oct 26, 2025

Using AI based signals to follow Neuphoria Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Automated trading signals detected on Neuphoria Therapeutics Inc.Exit Point & Momentum Based Trading Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesTrade Entry Summary & Weekly High Momentum Picks - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessTrade Exit Summary & Expert Curated Trade Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why analysts upgrade Neuphoria Therapeutics Inc. stockGold Moves & Daily Entry Point Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is Neuphoria Therapeutics Inc. stock attractive after correctionBear Alert & Real-Time Stock Movement Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Neuphoria Therapeutics Inc.’s volatility index tracking explainedPortfolio Profit Report & High Win Rate Trade Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why hedge funds are buying Neuphoria Therapeutics Inc. stockInsider Selling & Stepwise Trade Execution Plans - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsTrade Exit Summary & Weekly High Potential Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Best Biotech Stocks To Keep An Eye OnOctober 25th - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 10:45:26 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Neuphoria Therapeutics Advances BNC-210 Trial with Prolonged Cash Runway - StocksToTrade

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 11:32:54 - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Published on: 2025-10-25 19:04:06 - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Neuphoria Therapeutics Stock Gains Amid Phase 3 Trial Advances - StocksToTrade

Oct 25, 2025
pulisher
Oct 25, 2025

Neuphoria Therapeutics Advances Social Anxiety Drug in Key Phase 3 Trial - timothysykes.com

Oct 25, 2025

Neuphoria Therapeutics Inc (NEUP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
大文字化:     |  ボリューム (24 時間):